Stock market ends up on in-line inflation data but dangers lurk. Indexes drop on the month
US stocks rise after Fed's favorite inflation gauge matches forecasts. But lurking tariff and geopolitical risks keep indexes ...
JD Supra8h
Carbon fraud is on the rise—but so is the regulatory counteroffensive
At COP29 in Baku, new rules were adopted for carbon markets under Article 6 of the Paris Agreement. These rules are meant to increase the ...
Robinhood CFO sells $1.2M in shares following dropped SEC investigation
The sale comes as the platform is eyeing further expansion into the industry and follows on the heels of the SEC dropping an ...
Novartis Pharma AG: Novartis oral Fabhalta (iptacopan) receives positive CHMP opinion for the treatment of adults living with C3 glomerulopathy (C3G)
If approved, Fabhalta® will be the only medicine indicated to selectively target the underlying cause of C3G1, an ultra-rare, progressive kidney disease with no currently approved treatments2-5 Phase ...
manilatimes15h
Novartis oral Fabhalta® (iptacopan) receives positive CHMP opinion for the treatment of adults living with C3 glomerulopathy (C3G)
Fabhalta (iptacopan) is an oral, Factor B inhibitor of the alternative complement pathway 6-7.
A crypto mogul who invested millions into Trump coins is getting a reprieve on civil fraud charges
A businessman who pumped $75 million into the Trump family-backed crypto token finds himself in a fortunate position this week as federal securities regulators are hitting pause on their civil fraud ...